Daily S&P Biotech Bear 3x Shares falls -5.6%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 11 2024
0mins
- Current Market Performance: Daily S&P Biotech Bear 3x Shares has decreased by 5.6%, resulting in a drop of $0.35 to a price of $5.96.
- Market Context: This decline reflects ongoing trends in the biotech sector as of October 2023.
Analyst Views on LABD
Wall Street analysts forecast LABD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LABD is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 17.900
Low
Averages
High
Current: 17.900
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
